Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dishman Opens Dishman Netherlands, cGMP Laboratory
Dishman Netherlands has oppened its containment cGMP laboratory on November 27, 2009. It was inaugrated by Jay Vyas, chairman and owner of the Indian Dishman Group. Important attendees
Dishman Netherlands has oppened its containment cGMP laboratory on November 27, 2009. It was inaugrated by Jay Vyas, chairman and owner of the Indian Dishman Group. Important attendees
Wedgewood Pharmacy is compounding Tiny Tabs in Megestrol Acetate 5mg and Famciclovir 31.25mg, in response to requests from veterinarians. Megestrol Acetate is commonly prescribed by veterinarians for behavioral-
Eli Lilly has received FDA approval for Cymbalta (duloxetine HCl) for the maintenance treatment of generalised anxiety disorder (GAD) in adults, The efficacy and safety of Cymbalta for
Sanofi-aventis Canada has entered into a licensing agreement with Intelliject for a novel epinephrine auto injector for the emergency treatment of allergic reactions (anaphylaxis) in North America (US
Xencor has licensed its XmAb and Xtend technology platforms to Centocor Research & Development (Centocor) for the optimisation of Centocor’s antibody drug candidates. The license follows a 2009
eHealthSource.com has launched the first online shopping site dedicated to products approved for Flexible Spending Account or Health Savings Account (FSA/HSA) claims. The site is also the first
Ambrilia Biopharma has extended the license option agreement with ZBx that granted ZBx the worldwide rights to develop, manufacture and commercialise Ambrilia’s PSP94 technology in ZBx’s zap rapid
BioMarin has announced that the FDA has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has previously received
Allos has reported that the US Patent and Trademark Office (USPTO) has issued a patent for the use of Folotyn (pralatrexate injection) for the treatment of T-cell lymphoma.
The Defense Threat Agency (DTRA), on behalf of the US Air Force Assistant Surgeon General, Modernisation Directorate (AF/SGR), has awarded Idaho Technology, a $3.3m to advance development of